Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis (Q45885213)

17 December 2017

title

Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis (English)

1 reference

17 December 2017

0 references

1 reference

L Kowalczuk

4

0 references

author name string

E Touchard

1

1 reference

17 December 2017

C Bloquel

2

1 reference

17 December 2017

P Bigey

3

1 reference

17 December 2017

L Jonet

5

1 reference

17 December 2017

B Thillaye-Goldenberg

6

1 reference

17 December 2017

M-C Naud

7

1 reference

17 December 2017

D Scherman

8

1 reference

17 December 2017

Y de Kozak

9

1 reference

17 December 2017

D Benezra

10

1 reference

17 December 2017

F Behar-Cohen

11

1 reference

17 December 2017

publication date

14 May 2009

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

page(s)

862-873

1 reference

17 December 2017

The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU).

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Contribution of TNF-α to Leukocyte Adhesion, Vascular Leakage, and Apoptotic Cell Death in Endotoxin-Induced Uveitis In Vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Intraocular cytokine environment in active Behçet uveitis.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

TNF-857T, a genetic risk marker for acute anterior uveitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Anti-TNF therapies in the management of acute and chronic uveitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Anti-TNF-alpha therapy for sight threatening uveitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Adalimumab in the therapy of uveitis in childhood

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Anti-TNFα Therapy Modulates the Phenotype of Peripheral Blood CD4+T Cells in Patients with Posterior Segment Intraocular Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

High-dose infliximab prophylaxis in endotoxin-induced uveitis.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Etanercept treatment in the endotoxin-induced uveitis of rats.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Biologics in the treatment of uveitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Do tumor necrosis factor inhibitors cause uveitis? A registry-based study

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

TNFalpha blockade in human diseases: an overview of efficacy and safety

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

TNFalpha blockade in human diseases: mechanisms and future directions

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Local ocular immunomodulation resulting from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Intra-articular electrotransfer of plasmid encoding soluble TNF receptor variants in normal and arthritic mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Comparative anatomy of laboratory animal corneas with a new-generation high-resolution in vivo confocal microscope.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.43

7 January 2021

Identifiers

DOI

10.1038/GT.2009.43

1 reference

17 December 2017

Dimensions Publication ID

1008600798

0 references

1 reference

17 December 2017